Clinical Trials Directory

Trials / Completed

CompletedNCT02855879

Evaluation of the Prevalence of anomalIes of Glucose Metabolism in Patients Undergoing a Coronary Artery Bypass Graft (CABG)

Evaluation of the Prevalence of anomalIes of Glucose Metabolism in Patients Undergoing a Coronary Artery Bypass Graft, Consequences for Morbi/Mortality in the Short and Medium Term

Status
Completed
Phase
Study type
Observational
Enrollment
286 (actual)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to determine the prevalence of diabetes and non-diabetic glucose metabolism anomalies (glucose intolerance, non-diabetic fasting hyperglycaemia in patients about to undergo coronary artery bypass grafting (CABG). In addition, the effect of these anomalies on post CABG morbi/mortality in the short term will be evaluated.

Conditions

Interventions

TypeNameDescription
OTHERCollection of biological data
OTHERCollection of clinical data

Timeline

Start date
2015-04-08
Primary completion
2019-06-05
Completion
2019-06-05
First posted
2016-08-04
Last updated
2019-12-11

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02855879. Inclusion in this directory is not an endorsement.

Evaluation of the Prevalence of anomalIes of Glucose Metabolism in Patients Undergoing a Coronary Artery Bypass Graft (C (NCT02855879) · Clinical Trials Directory